Menu
miSRA: search preprocessed public small-RNA data against your reference sequences (miRNA, tRNA, etc)
ugr
Filter the database to select the samples
Name Exp Study TaxonID SampleTag SampleTag2 LibraryInf Disease Method
Mus musculus DRX122056 DRP004212 10090 bone marrow treatment: cultured in DMEM for 5h NEB NA NA
Austrofundulus limnaeus SRX2562350 SRP058458 52670 Whole Embryo tissue: Whole Embryo Illumina_2 NA NA
Caenorhabditis elegans SRX2826562 SRP107241 6239 Whole worm cell lysate, Gravid Adult genotype: alg-5(tm1163) I; alg-5::3xHA::alg-5 II Illumina NA extract_protocol: Small RNAs (18-28-nt) were purified from total RNA by size selection using 17% polyacrylamide gels and treated with RNA polyphosphatase or Tobacco Alkaline Phosphatase to facilitate capture of 22G-RNAs, followed by ligation of preadenylated 3’ adapters and non-adenylated 5’ adapters. Adapter-ligated small RNAs were size selected at each ligation step from 12-15% polyacrylamide gels. Adapter-bound small RNAs were reverse transcribed and then amplified using PCR. PCR products (~136-146 bp) were size selected from 10% polyacrylamide gels
Caenorhabditis elegans SRX2826561 SRP107241 6239 Whole worm cell lysate, Gravid Adult genotype: alg-5(tm1163) I Illumina NA extract_protocol: Small RNAs (18-28-nt) were purified from total RNA by size selection using 17% polyacrylamide gels and treated with RNA polyphosphatase or Tobacco Alkaline Phosphatase to facilitate capture of 22G-RNAs, followed by ligation of preadenylated 3’ adapters and non-adenylated 5’ adapters. Adapter-ligated small RNAs were size selected at each ligation step from 12-15% polyacrylamide gels. Adapter-bound small RNAs were reverse transcribed and then amplified using PCR. PCR products (~136-146 bp) were size selected from 10% polyacrylamide gels
Caenorhabditis elegans SRX2826560 SRP107241 6239 Whole worm cell lysate, Gravid Adult genotype: N2 Illumina NA extract_protocol: Small RNAs (18-28-nt) were purified from total RNA by size selection using 17% polyacrylamide gels and treated with RNA polyphosphatase or Tobacco Alkaline Phosphatase to facilitate capture of 22G-RNAs, followed by ligation of preadenylated 3’ adapters and non-adenylated 5’ adapters. Adapter-ligated small RNAs were size selected at each ligation step from 12-15% polyacrylamide gels. Adapter-bound small RNAs were reverse transcribed and then amplified using PCR. PCR products (~136-146 bp) were size selected from 10% polyacrylamide gels
Caenorhabditis elegans SRX2826567 SRP107241 6239 Whole worm cell lysate, Late L4 genotype: alg-5(ram-2) I Illumina NA extract_protocol: Small RNAs (18-28-nt) were purified from total RNA by size selection using 17% polyacrylamide gels and treated with RNA polyphosphatase or Tobacco Alkaline Phosphatase to facilitate capture of 22G-RNAs, followed by ligation of preadenylated 3’ adapters and non-adenylated 5’ adapters. Adapter-ligated small RNAs were size selected at each ligation step from 12-15% polyacrylamide gels. Adapter-bound small RNAs were reverse transcribed and then amplified using PCR. PCR products (~136-146 bp) were size selected from 10% polyacrylamide gels
Caenorhabditis elegans SRX2826566 SRP107241 6239 Whole worm cell lysate, Late L4 genotype: N2 Illumina NA extract_protocol: Small RNAs (18-28-nt) were purified from total RNA by size selection using 17% polyacrylamide gels and treated with RNA polyphosphatase or Tobacco Alkaline Phosphatase to facilitate capture of 22G-RNAs, followed by ligation of preadenylated 3’ adapters and non-adenylated 5’ adapters. Adapter-ligated small RNAs were size selected at each ligation step from 12-15% polyacrylamide gels. Adapter-bound small RNAs were reverse transcribed and then amplified using PCR. PCR products (~136-146 bp) were size selected from 10% polyacrylamide gels
Caenorhabditis elegans SRX2826565 SRP107241 6239 Whole worm cell lysate, Late L4 genotype: alg-5(ram-1[GFP::3xFLAG::alg-5 + loxP]) I Illumina NA extract_protocol: Small RNAs (18-28-nt) were purified from total RNA by size selection using 17% polyacrylamide gels and treated with RNA polyphosphatase or Tobacco Alkaline Phosphatase to facilitate capture of 22G-RNAs, followed by ligation of preadenylated 3’ adapters and non-adenylated 5’ adapters. Adapter-ligated small RNAs were size selected at each ligation step from 12-15% polyacrylamide gels. Adapter-bound small RNAs were reverse transcribed and then amplified using PCR. PCR products (~136-146 bp) were size selected from 10% polyacrylamide gels
Caenorhabditis elegans SRX2826564 SRP107241 6239 Whole worm cell lysate, Late L4 genotype: alg-5(ram-1[GFP::3xFLAG::alg-5 + loxP]) I Illumina NA extract_protocol: Small RNAs (18-28-nt) were purified from total RNA by size selection using 17% polyacrylamide gels and treated with RNA polyphosphatase or Tobacco Alkaline Phosphatase to facilitate capture of 22G-RNAs, followed by ligation of preadenylated 3’ adapters and non-adenylated 5’ adapters. Adapter-ligated small RNAs were size selected at each ligation step from 12-15% polyacrylamide gels. Adapter-bound small RNAs were reverse transcribed and then amplified using PCR. PCR products (~136-146 bp) were size selected from 10% polyacrylamide gels
Homo sapiens SRX12265127 SRP337938 9606 Plasma sample type: Normal - Cancer-free other NA NA
Homo sapiens SRX12265125 SRP337938 9606 Plasma sample type: Normal - Cancer-free other NA NA
Caenorhabditis elegans SRX23442614 SRP486660 6239 whole animals tissue: whole animals NEB NA NA
Caenorhabditis elegans SRX23442613 SRP486660 6239 whole animals tissue: whole animals NEB NA NA
Homo sapiens SRX12265123 SRP337938 9606 Plasma sample type: Normal - Cancer-free other NA NA
Homo sapiens SRX8804169 SRP273213 9606 plasma tissue: plasma adapter_trimmed NA NA